Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis B immunization--when is a booster injection necessary?].

P J Grob, A Dufek, H I Joller-Jemelka

    Schweizerische Medizinische Wochenschrift
    |March 23, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity.

    Andrologia·2003
    Same author

    Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthma.

    Allergy·2003
    Same author

    [Hepatitis B virus infection: diagnosis, clinical sequelae, therapy and prevention].

    Praxis·2002
    Same author

    Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection.

    Journal of acquired immune deficiency syndromes (1999)·2001
    Same author

    Markers for cell-mediated immune response are elevated in cerebrospinal fluid and serum after severe traumatic brain injury in humans.

    Journal of neurotrauma·2001
    Same author

    [Hepatitis C virus infection. Overview. SEVHEP (Swiss Experts on Viral Hepatitis)].

    Praxis·2000
    Same journal

    Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Boeck's disease as a tuberculous syndrome.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Enteral primary tubercular complexes

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Tuberculous stenoses of the large bronchi.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    About the enzyme action.

    Schweizerische medizinische Wochenschrift·2010
    See all related articles

    Hepatitis B vaccine booster injections are recommended based on initial antibody levels and individual risk factors. Antibody persistence varies, with higher initial concentrations offering longer protection against hepatitis B.

    Area of Science:

    • Immunology
    • Vaccinology
    • Public Health

    Background:

    • Hepatitis B vaccination is crucial for high-risk populations.
    • The need for and timing of booster doses after initial hepatitis B vaccination require clarification.

    Purpose of the Study:

    • To analyze the concentration and persistence of anti-HBs antibodies in individuals vaccinated against hepatitis B.
    • To inform decisions regarding hepatitis B booster vaccination strategies.

    Main Methods:

    • Analysis of anti-HBs antibody levels in 158 successfully vaccinated individuals (medical staff, hemodialysis patients, renal transplant recipients).
    • Tracking antibody concentrations over time post-vaccination.
    • Correlating initial antibody titers with long-term persistence.

    Related Experiment Videos

    Main Results:

    • Anti-HBs antibody levels peaked around 7 months post-vaccination and gradually declined.
    • Antibody persistence was directly related to the initial maximum anti-HBs concentration achieved.
    • After 3 years, antibody levels fell below 10 mIU/ml in all healthy individuals with low initial titers, and in a significant percentage of those with moderate initial titers.

    Conclusions:

    • Booster vaccination policies should consider individual initial antibody responses.
    • Measuring anti-HBs levels post-initial immunization can guide personalized booster recommendations.
    • Higher initial antibody concentrations correlate with prolonged protection against hepatitis B.